Immunovant, Inc. (IMVT) Misses Q2 EPS by 4c
Get Alerts IMVT Hot Sheet
Join SI Premium – FREE
Immunovant, Inc. (NASDAQ: IMVT) reported Q2 EPS of ($0.41), $0.04 worse than the analyst estimate of ($0.37).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Starts Immunovant (IMVT) at Outperform, 'expect the execution to unlock considerable value'
- Recruit Holdings Co., Ltd (6098:JP) (RCRUY) PT Raised to JPY7,800 at Jefferies, 'emerged stronger since the last earnings season'
- 22nd Century Group (XXII) Reports Q4 Revenue of $7.4M, Net Loss of $22.1M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!